Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-Current Assets (2016 - 2025)

OptimizeRx (OPRX) has disclosed Non-Current Assets for 16 consecutive years, with $112.2 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 4.26% to $112.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $457.4 million through Dec 2025, up 102.59% year-over-year, with the annual reading at $112.2 million for FY2025, 4.26% down from the prior year.
  • Non-Current Assets hit $112.2 million in Q4 2025 for OptimizeRx, down from $114.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $128.9 million in Q4 2023 to a low of $25.4 million in Q1 2022.
  • Historically, Non-Current Assets has averaged $71.3 million across 5 years, with a median of $36.8 million in 2022.
  • Biggest five-year swings in Non-Current Assets: soared 257.3% in 2023 and later fell 9.23% in 2025.
  • Year by year, Non-Current Assets stood at $25.9 million in 2021, then skyrocketed by 39.43% to $36.1 million in 2022, then skyrocketed by 257.3% to $128.9 million in 2023, then fell by 9.07% to $117.2 million in 2024, then dropped by 4.26% to $112.2 million in 2025.
  • Business Quant data shows Non-Current Assets for OPRX at $112.2 million in Q4 2025, $114.0 million in Q3 2025, and $115.2 million in Q2 2025.